Integration of growth factor and nutrient signaling: implications for cancer biology - PubMed (original) (raw)
Review
Integration of growth factor and nutrient signaling: implications for cancer biology
Alykhan F Shamji et al. Mol Cell. 2003 Aug.
Free article
Abstract
Signaling networks that promote cell growth are frequently dysregulated in cancer. One regulatory network, which converges on effectors such as 4EBP1 and S6K1, leads to growth by promoting protein synthesis. Here, we discuss how this network is regulated by both extracellular signals, such as growth factors, and intracellular signals, such as nutrients. We discuss how mutations amplifying either type of signal can lead to tumor formation. In particular, we focus on the recent discovery that a tumor suppressor complex whose function is lost in tuberous sclerosis patients regulates the nutrient signal carried by the critical signaling protein TOR to the effectors 4EBP1 and S6K1. Finally, we describe how the small molecule rapamycin, which inhibits TOR and thereby the activation of these effectors, could be useful to treat tumors that have become dependent upon this pathway for growth.
Similar articles
- Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E.
Fingar DC, Salama S, Tsou C, Harlow E, Blenis J. Fingar DC, et al. Genes Dev. 2002 Jun 15;16(12):1472-87. doi: 10.1101/gad.995802. Genes Dev. 2002. PMID: 12080086 Free PMC article. - Tumor-promoting phorbol esters and activated Ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribosomal S6 kinase.
Roux PP, Ballif BA, Anjum R, Gygi SP, Blenis J. Roux PP, et al. Proc Natl Acad Sci U S A. 2004 Sep 14;101(37):13489-94. doi: 10.1073/pnas.0405659101. Epub 2004 Sep 1. Proc Natl Acad Sci U S A. 2004. PMID: 15342917 Free PMC article. - Blockade of fatty acid synthase induces ubiquitination and degradation of phosphoinositide-3-kinase signaling proteins in ovarian cancer.
Tomek K, Wagner R, Varga F, Singer CF, Karlic H, Grunt TW. Tomek K, et al. Mol Cancer Res. 2011 Dec;9(12):1767-79. doi: 10.1158/1541-7786.MCR-10-0467. Epub 2011 Oct 4. Mol Cancer Res. 2011. PMID: 21970855 - Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression.
Fingar DC, Blenis J. Fingar DC, et al. Oncogene. 2004 Apr 19;23(18):3151-71. doi: 10.1038/sj.onc.1207542. Oncogene. 2004. PMID: 15094765 Review. - The TOR kinases link nutrient sensing to cell growth.
Rohde J, Heitman J, Cardenas ME. Rohde J, et al. J Biol Chem. 2001 Mar 30;276(13):9583-6. doi: 10.1074/jbc.R000034200. Epub 2001 Feb 2. J Biol Chem. 2001. PMID: 11266435 Review.
Cited by
- Rapamycin and mTOR: a serendipitous discovery and implications for breast cancer.
Seto B. Seto B. Clin Transl Med. 2012 Nov 15;1(1):29. doi: 10.1186/2001-1326-1-29. Clin Transl Med. 2012. PMID: 23369283 Free PMC article. - Growth and Metabolic Response of Chinese Perch to Different Dietary Protein-to-Energy Ratios in Artificial Diets.
Alam MS, Liang XF, Liu L, He S, Kuang Y, Hoseinifar SH, Dawar FU. Alam MS, et al. Int J Mol Sci. 2019 Nov 28;20(23):5983. doi: 10.3390/ijms20235983. Int J Mol Sci. 2019. PMID: 31795078 Free PMC article. - Rapamycin Upregulates Connective Tissue Growth Factor Expression in Hepatic Progenitor Cells Through TGF-β-Smad2 Dependent Signaling.
Wu Y, Wang W, Peng XM, He Y, Xiong YX, Liang HF, Chu L, Zhang BX, Ding ZY, Chen XP. Wu Y, et al. Front Pharmacol. 2018 Aug 8;9:877. doi: 10.3389/fphar.2018.00877. eCollection 2018. Front Pharmacol. 2018. PMID: 30135653 Free PMC article. - Dual inhibition of tumor energy pathway by 2-deoxyglucose and metformin is effective against a broad spectrum of preclinical cancer models.
Cheong JH, Park ES, Liang J, Dennison JB, Tsavachidou D, Nguyen-Charles C, Wa Cheng K, Hall H, Zhang D, Lu Y, Ravoori M, Kundra V, Ajani J, Lee JS, Ki Hong W, Mills GB. Cheong JH, et al. Mol Cancer Ther. 2011 Dec;10(12):2350-62. doi: 10.1158/1535-7163.MCT-11-0497. Epub 2011 Oct 12. Mol Cancer Ther. 2011. PMID: 21992792 Free PMC article. - An approach to analyse the specific impact of rapamycin on mRNA-ribosome association.
Genolet R, Araud T, Maillard L, Jaquier-Gubler P, Curran J. Genolet R, et al. BMC Med Genomics. 2008 Aug 1;1:33. doi: 10.1186/1755-8794-1-33. BMC Med Genomics. 2008. PMID: 18673536 Free PMC article.